Particle.news

Download on the App Store

Death Toll Rises to 23 in India Cough Syrup Case as Pharma Owner Arrested

Tests found extreme diethylene glycol contamination, triggering nationwide recalls, audits, criminal action.

Overview

  • A one-year-old child died in Nagpur on Thursday, taking the toll to 23, with several other children from Madhya Pradesh still hospitalised and some in critical condition.
  • Madhya Pradesh’s Special Investigation Team arrested Sresan Pharmaceuticals owner G. Ranganathan in Chennai, seized records and samples, and moved to secure transit remand to Chhindwara.
  • India’s drug regulator recalled three syrups — Coldrif, Respifresh TR and ReLife — ordered production halts, and launched a pan-India inspection and testing drive of cough syrup makers.
  • Tamil Nadu authorities sealed Sresan’s Kancheepuram unit, suspended two senior drug inspectors, and confirmed batch SR-13 contained about 48.6% diethylene glycol, with licence cancellation under consideration.
  • WHO flagged domestic screening gaps and said India reported no exports of the contaminated syrups, while a Supreme Court petition seeking a court-monitored probe is slated to be heard on Friday.